Mélanie Buchi
Impact in
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
-
- Adenosine and Purinergic Signaling
Papers in
-
- Immunotherapy and Immune Responses 3
- Immune Cell Function and Interaction 3
- Immune cells in cancer 2
- Phagocytosis and Immune Regulation 1
- Oncology 5
- Cancer Immunotherapy and Biomarkers 4
- CAR-T cell therapy research 2
- Co-authors
- Alfred Zippelius (6 shared papers)Abhishek S. Kashyap (5 shared papers)Philipp Müller (2 shared papers)Lucia D’Amico (2 shared papers)Heinz Läubli (2 shared papers)Roger R. Beerli (1 shared paper)Ulf Grawunder (1 shared paper)Iva Truxová (1 shared paper)
- Journals
- Journal for ImmunoTherapy of Cancer (3 papers)Cancer Immunology Immunotherapy (1 paper)Frontiers in Oncology (1 paper)Cancer Immunology Research (1 paper)
- Partner nations
- SwitzerlandGermanyFrance
In The Last Decade
Mélanie Buchi
5 papers receiving 223 citations
Peers
Comparison fields: 5 of 43
- Oncology 133
- Physiology 22
- Immunology 92
- Radiology, Nuclear Medicine and Imaging 34
- Cancer Research 22
Countries citing papers authored by Mélanie Buchi
This map shows the geographic impact of Mélanie Buchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélanie Buchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélanie Buchi more than expected).
Fields of papers citing papers by Mélanie Buchi
This network shows the impact of papers produced by Mélanie Buchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélanie Buchi. The network helps show where Mélanie Buchi may publish in the future.
Co-authors
The 25 scholars most cited alongside Mélanie Buchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 89 | |
| 2 | 2019 | 51 | |
| 3 | 2018 | 42 | |
| 4 | 2021 | 28 | |
| 5 | 2023 | 14 | |
| 6 | 2025 | 0 |
About Mélanie Buchi
Mélanie Buchi is a scholar working on Immunology, Oncology, Molecular Biology, Physiology and Biotechnology, having authored 6 papers that have together received 224 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (3 papers), Immune Cell Function and Interaction (3 papers), CAR-T cell therapy research (2 papers), Immune cells in cancer (2 papers), RNA Interference and Gene Delivery (1 paper), Phagocytosis and Immune Regulation (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Oncology (133 citations), Physiology (22 citations), Immunology (92 citations), Radiology, Nuclear Medicine and Imaging (34 citations) and Cancer Research (22 citations). Mélanie Buchi has collaborated with scholars based in Switzerland, Germany and France. Frequent co-authors include Alfred Zippelius, Abhishek S. Kashyap, Philipp Müller, Lucia D’Amico, Heinz Läubli, Roger R. Beerli, Ulf Grawunder, Iva Truxová, Sandra M. Kallert and Julia Festag. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Cancer Immunology Immunotherapy, Frontiers in Oncology and Cancer Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.